23andMe Lays Off 40% of Staff, Shuts Drug Development Business

HS 11/11/2024
Advertisements




The genetics company is closing a unit that was once seen as core to its future.



Source link

More Stories

General Motors is set to report earnings before the bell. Here's what Wall Street expects

HS 27/04/2026

Saba Capital finds little appetite for tender offer of shares in Blue Owl, Starwood private credit funds

HS 27/04/2026

Stocks making the biggest moves after hours: LendingClub, Nucor, Rambus, Bed Bath & Beyond and more

HS 27/04/2026

You may have missed

Oil major BP beats profit expectations as Iran war boosts fuel prices

HS 27/04/2026

Iran running out of space to store its crude oil; is the real financial crisis still coming? – The Times of India

HS 27/04/2026

Off target: Internet erupts over Vaibhav Sooryavanshi question to Manu Bhaker

HS 27/04/2026

General Motors is set to report earnings before the bell. Here's what Wall Street expects

HS 27/04/2026

Bank of Japan keeps policy rate steady while raising inflation forecast on Iran war worries

HS 27/04/2026